| AD | Atopic dermatitis |
| CIR | Cosmetic Ingredient Review |
| CS | Chondroitin sulphate |
| DEJ | Dermoepidermal junction |
| DOX | Docetaxel |
| Dx/HA | Dextranomer/hyaluronic acid copolymer |
| ECM | Extracellular matrix |
| FSFI | Female sexual function index |
| HA | Hyaluronic acid |
| HARE | Hyaluronan receptor for endocytosis |
| HMW-HA | High molecular weight hyaluronic acid |
| IOP | Intraocular pressure |
| KHA | Potassium hyaluronate |
| LMW-HA | Low molecular weight hyaluronic acid |
| LYVE1 | Lymphatic vessel endothelial hyaluronan receptor-1 |
| MMW-HA | Medium molecular weight hyaluronic acid |
| MSCs | Mesenchymal stronal cells |
| NaHA | Sodium hyaluronate |
| NP | Nanoparticles |
| OVD | Ophthalmic viscoelastic device |
| PLOD 3 | Procollagen-lysine, oxoglutarate 5-dioxygenase 3 |
| PTX | Paclitaxel |
| RHAMM | Receptor for hyaluronan-mediated motility |
| SC | Stratum corneum |
| SOD | Superoxide dismutase |
| TEWL | Transepidermal water loss |
| TLR | Toll-like receptor |
| TNF-α | Tumor necrosis factor-α |
| UTI | Urinary tract infection |
| VUR | Vesicoureteral reflux |